In its wisdom, the state giveth and the state taketh away. When it acquires farmlands claiming eminent domain, there is blood on the streets. However, when it quietly bestows largesse on chosen ones, it is barely noticed. At worst there is a lawsuit. There were a dozen lengthy judgments from the Supreme Court in the past two months on land acquisition disputes — a mark of the times. But the biased...

-The Hindu   The Uttar Pradesh government's new land acquisition policy, announced in the face of farmers' protests and impending elections, is a significant improvement over existing practices. It is sounder than the amendments to the central Act proposed by the UPA government, which have been awaiting enactment since 2007. Poor compensation calculated on rates based on the pre-development phase, a lack of consultation, and cumbersome procedures have marred the whole...

-The Business Standard   Five political parties stage protest against land acquisition Tension prevailed on Monday at the proposed Posco project site at Gobindpur village under Dhinkia panchayat as ten platoons of armed police conducted flag march ostensibly to create a fear psychosis among the local people ahead of the land acquisition process at trouble-torn Dhinkia panchayat. The situation is going to very critical at Gobindpur as the activists of Posco Pratirodha Sangram Samiti...

Senior lawyer and Kashmir Committee chief Ram Jethmalani has demanded that the Armed Forces Special Powers Act and the Public Safety Act be revoked, expressing concern at the human rights situation in the State. At the end of the committee's five-day visit to Kashmir, he told journalists that New Delhi was partly responsible for the situation. He said he would constitute a group of lawyers in Delhi to fight the cases...

Rs 3 lakh – that's the price a pharmaceutical company has paid to the family of a person who died in their clinical trial. Others weren't even this lucky. According to the Drug Controller General of India's (DCGI) records, 25 people died in clinical trials carried out by nine pharmaceutical companies in 2010. Families of five of these victims received "compensation for trial related death" — the amount ranging from Rs...